๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Central nervous system lnvolvement in malignant melanoma

โœ Scribed by Spyros Retsas; Anthony R. Gershuny

Book ID
102670570
Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
801 KB
Volume
61
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Failure of adjuvant immunotherapy to pre
Failure of adjuvant immunotherapy to prevent central nervous system metastases in malignant melanoma patients
โœ Gary A. Grooms; Frederick R. Eilber; Donald L. Morton ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 368 KB

## Abstract A review of our experience using BCG immunotherapy as a postsurgical adjunct in the treatment of melanoma shows that the incidence of systemic metastases appears to have been reduced. However, central nervous system (CNS) metastases continue to develop in these patients and represent th

Telomerase activity in central nervous s
Telomerase activity in central nervous system malignant lymphoma
โœ Kunyu Harada; Kaoru Kurisu; Kazunori Arita; Takashi Sadatomo; Hidetoshi Tahara; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 2 views

BACKGROUND. Primary central nervous system malignant lymphoma (PCNSL) has been regarded as a rare neoplasm. Recently, however, its incidence has been rapidly increasing. Despite active clinical trials, its clinical and biologic features remain unknown and there has been no effective treatment or pro